cromakalim has been researched along with sr141716 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiley, CR; White, R | 2 |
| Dinc, M; Oz, M; Shippenberg, TS; Yang, KH | 1 |
3 other study(ies) available for cromakalim and sr141716
| Article | Year |
|---|---|
Endothelium and cannabinoid receptor involvement in levcromakalim vasorelaxation.
Topics: Animals; Cromakalim; Dose-Response Relationship, Drug; Endothelium, Vascular; Guanidines; Male; Mesenteric Arteries; Pinacidil; Piperidines; Potassium Channels; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Vasodilation; Vasodilator Agents | 1997 |
The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery.
Topics: Animals; Benzimidazoles; Calcium; Cannabinoids; Carbachol; Cromakalim; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; In Vitro Techniques; Male; Mesenteric Arteries; Methoxamine; Muscle Relaxation; Muscle, Smooth, Vascular; Penicillamine; Piperidines; Potassium Channels; Pyrazoles; Rats; Rats, Wistar; Rimonabant | 1998 |
The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.
Topics: Animals; Arachidonic Acids; Calcium; Camphanes; Cromakalim; Egtazic Acid; Endocannabinoids; Female; Glyburide; KATP Channels; Oocytes; Pertussis Toxin; Piperidines; Polyunsaturated Alkamides; Potassium Channel Blockers; Pyrazoles; Rimonabant; Xenopus laevis | 2007 |